share_log

Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)

Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)

禮來 | SC TO-T/A:發行招標公告
美股SEC公告 ·  08/05 17:07
Moomoo AI 已提取核心訊息
Eli Lilly and Company, through its subsidiary Rainier Acquisition Corporation, has made a tender offer to acquire all outstanding shares of Morphic Holding, Inc. at $57.00 per share in cash. The offer, initially filed on July 19, 2024, is set to expire on August 15, 2024, unless extended or terminated earlier. Amidst this acquisition process, several lawsuits have been filed against Morphic and its board members, alleging failure to disclose material information in connection with the tender offer and seeking injunctions, revisions to disclosures, rescission of the transactions, or damages. The complaints were filed by purported Morphic stockholders in both federal and state courts. Eli Lilly has indicated that additional lawsuits may arise but will not necessarily announce such complaints unless they contain materially new or different allegations.
Eli Lilly and Company, through its subsidiary Rainier Acquisition Corporation, has made a tender offer to acquire all outstanding shares of Morphic Holding, Inc. at $57.00 per share in cash. The offer, initially filed on July 19, 2024, is set to expire on August 15, 2024, unless extended or terminated earlier. Amidst this acquisition process, several lawsuits have been filed against Morphic and its board members, alleging failure to disclose material information in connection with the tender offer and seeking injunctions, revisions to disclosures, rescission of the transactions, or damages. The complaints were filed by purported Morphic stockholders in both federal and state courts. Eli Lilly has indicated that additional lawsuits may arise but will not necessarily announce such complaints unless they contain materially new or different allegations.
伊萊利莉公司通過其子公司Rainier Acquisition Corporation提出要約收購Morphic Holding Inc.的所有未流通股票,以每股57.00美元的現金價格收購。這份報價最初於2024年7月19日提交,將於2024年8月15日到期,除非提前或終止。在此收購過程中,多起訴訟已經針對Morphic及其董事會成員提起,聲稱未披露與要約收購有關的重要信息,要求禁令,修訂披露文件,解除交易或索賠。這些申訴是由所謂的Morphic股東在聯邦和州法院提起的。伊萊利莉公司表示可能會有額外的訴訟,但不一定會公佈此類訴訟,除非它們包含了實質性的新指控。
伊萊利莉公司通過其子公司Rainier Acquisition Corporation提出要約收購Morphic Holding Inc.的所有未流通股票,以每股57.00美元的現金價格收購。這份報價最初於2024年7月19日提交,將於2024年8月15日到期,除非提前或終止。在此收購過程中,多起訴訟已經針對Morphic及其董事會成員提起,聲稱未披露與要約收購有關的重要信息,要求禁令,修訂披露文件,解除交易或索賠。這些申訴是由所謂的Morphic股東在聯邦和州法院提起的。伊萊利莉公司表示可能會有額外的訴訟,但不一定會公佈此類訴訟,除非它們包含了實質性的新指控。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息